Resultados de la búsqueda 1-10 of 9572 for hla genotype

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  5. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...

  6. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  8. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...

  9. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...

  10. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...